ACTIVE

Labotoxico

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result-28,2 k €+84,5 %over 1 year

Gross margin134,2 k €+243,2 %over 1 year

Equity2,5 M €-1,1 %over 1 year

Workforce0,0 ETP

Identity

Source · BCE/KBO

Labotoxico is a Public limited company incorporated in 1987. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Damme.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0432.685.722
Incorporation: 20/11/1987
Legal form: Public limited company
Registered office: Dorpsstraat 110
8340 Damme · FlandreSee on map
Contributed capital: 62 000,00 €
Latest accounts: 30/06/2025
Average workforce: 0,0 ETP

Activities (NACE)

47740Retail sale of medical and orthopaedic goods in specialised stores· main 47741Retail sale of medical and orthopaedic goods in specialised stores 85141Pre-primary education 32500Manufacture of medical and dental instruments and supplies 32500Manufacture of medical and dental instruments and supplies 68100Buying and selling of own real estate+8

Joint committees (4)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 18 financial years

	2025		2024		2023		2022		2020
Income statement
Gross margin	134,2 k €	+243%	39,1 k €	-38.4%	63,5 k €	-36.8%	100,5 k €	-0.9%	101,3 k €
EBITDA	120,8 k €	+462%	-33,4 k €	-155%	60,5 k €	-36.5%	95,4 k €	+13.4%	84,1 k €
Operating result	-33,8 k €	+81.6%	-183,2 k €	-159%	-70,8 k €	-2940%	2,5 k €	-86.8%	18,8 k €
Net result	-28,2 k €	+84.5%	-181,9 k €	-160%	-70 k €	-437%	20,8 k €	+116%	9,6 k €
Balance sheet
Equity	2,5 M €	-1.1%	2,5 M €	-6.8%	2,7 M €	-2.5%	2,8 M €	+0.8%	2,7 M €
Total assets	4,1 M €	-2.2%	4,1 M €	+1.9%	4,1 M €	+11.9%	3,6 M €	+9.6%	3,3 M €
Cash	114,5 k €	+61.7%	70,8 k €	-12.5%	80,9 k €	-50.0%	161,9 k €	-62.0%	425,5 k €
Debts	1,3 M €	-3.7%	1,4 M €	+24.1%	1,1 M €	+85.6%	605,8 k €	+155%	237,9 k €
Other
Workforce	0,0 ETP		0,0 ETP		0,0 ETP		–		0,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

2 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Anne Leenesonne	Director21/12/2017 → 19/12/2029
APOCHEM0479.416.560Represented by Cordonnier JAN	Director21/12/2017 → 19/12/2029Managing director03/11/2011 → 2020 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jan CORDONNIER	Director03/11/2011 → 2021 accounts
EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM0435.237.515Represented by Jan CORDONNIER	Directoruntil 03/11/2011

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/01/2026	27/01/2025	30/01/2024	31/01/2023	27/01/2022	26/01/2021
General meeting	17/12/2025	18/12/2024	20/12/2023	21/12/2022	15/12/2021	16/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	17/12/2025	26/01/2026	Dutch	PDF
Abridged model	30/06/2024	18/12/2024	27/01/2025	Dutch	PDF
Abridged model	30/06/2023	20/12/2023	30/01/2024	Dutch	PDF
Abridged model	30/06/2022	21/12/2022	31/01/2023	Dutch	PDF
Abridged model	30/06/2021	15/12/2021	27/01/2022	Dutch	PDF
Abridged model	30/06/2020	16/12/2020	26/01/2021	Dutch	PDF
Abridged model	30/06/2019	08/01/2020	31/01/2020	Dutch	PDF
Abridged model	30/06/2018	19/12/2018	28/01/2019	Dutch	PDF
Abridged model	30/06/2017	20/12/2017	25/01/2018	Dutch	PDF
Abridged model	30/06/2016	21/12/2016	13/01/2017	Dutch	PDF
Abridged model	30/06/2015	16/12/2015	15/01/2016	Dutch	PDF
Abridged model	30/06/2014	17/12/2014	15/01/2015	Dutch	PDF
Abridged model	30/06/2013	27/11/2013	14/02/2014	Dutch	PDF
Abridged model	30/06/2012	19/12/2012	14/02/2013	Dutch	PDF
Abridged model	30/06/2011	21/12/2011	15/02/2012	Dutch	PDF
Abridged model	30/06/2010	15/12/2010	31/01/2011	Dutch	PDF
Abridged model	30/06/2009	16/12/2009	31/01/2010	Dutch	PDF
Abridged model	30/06/2008	17/12/2008	30/01/2009	Dutch	PDF
Abridged model	30/06/2007	19/12/2007	30/01/2008	Dutch	PDF
Abridged model	30/06/2006	20/12/2006	30/01/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

2 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Anne Leenesonne	Director21/12/2017 → 19/12/2029
APOCHEM0479.416.560Represented by Cordonnier JAN	Director21/12/2017 → 19/12/2029Managing director03/11/2011 → 2020 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jan CORDONNIER	Director03/11/2011 → 2021 accounts
EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM0435.237.515Represented by Jan CORDONNIER	Directoruntil 03/11/2011

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates12/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/07/2022
ONTSLAGEN - BENOEMINGEN
PDF
Registered office06/09/2019
MAATSCHAPPELIJKE ZETEL
PDF
Mandates09/02/2018
ONTSLAGEN - BENOEMINGEN
PDF
Other17/05/2017
STATUTENWIJZIGING
PDF
Other19/04/2013
DOEL
PDF
Mandates31/01/2012
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares17/01/2012
KAPITAAL - AANDELEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

APOCHEM

Anne Leenesonne

Jan CORDONNIER

EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

Labotoxico

Dorpsstraat 110, 8340 Damme

DirectorManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Dorpsstraat 110, 8340 DammeCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00013367

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
LabotoxicoCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00013367

Events

2025
Annual accounts 2025-28,2 k €↑
2024
Annual accounts 2024-181,9 k €↓
2023
Annual accounts 2023-70 k €↓
2022
Annual accounts 202220,8 k €↑
2020
Annual accounts 20209,6 k €↓
2019
Annual accounts 2019385,4 k €↑
2018
Annual accounts 201812,5 k €↓
2017
Annual accounts 2017499,4 k €↑
2016
Annual accounts 201632,3 k €↓
2015
Annual accounts 201537,6 k €↑
2014
Annual accounts 201415,2 k €↓
2013
Annual accounts 201362,6 k €↓
2012
Annual accounts 2012147,8 k €↓
2011
Annual accounts 2011289,8 k €↑
2010
Annual accounts 2010237,8 k €↓
2009
Annual accounts 2009263,8 k €↑
2008
Annual accounts 2008201 k €↓
2007
Annual accounts 2007427 k €
20/11/1987
IncorporationPublic limited company

Labotoxico

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events